TNXP

Tonix Pharmaceuticals Holding Stock Analysis

AI Rating

Good
  • Quality3/10
  • Growth↓ 4/10
  • Value↑ 10/10
Tonix Pharmaceuticals Holding sales and earnings growth
TNXP Growth
Neutral
  • Revenue Y/Y↑ 29.85%
  • EPS Y/Y↑ 91.75%
  • FCF Y/Y↓ -69.08%
Tonix Pharmaceuticals Holding gross and profit margin trends
TNXP Profitability
Fair
  • Gross margin ↑ 49.30%
  • EPS margin↓ -946.20%
  • ROIC 5Y↓ -165.90%
Tonix Pharmaceuticals Holding net debt vs free cash flow
TNXP Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↓ -1392.5

Tonix Pharmaceuticals Holding stock volatility is in-line with the overall market. We give it a Great risk rating.

More Biotechnology stocks ↗